165 related articles for article (PubMed ID: 31406471)
41. IL-29 enhances Toll-like receptor-mediated IL-6 and IL-8 production by the synovial fibroblasts from rheumatoid arthritis patients.
Xu L; Feng X; Tan W; Gu W; Guo D; Zhang M; Wang F
Arthritis Res Ther; 2013 Oct; 15(5):R170. PubMed ID: 24286242
[TBL] [Abstract][Full Text] [Related]
42. Activation of matrix metalloproteinases 2, 9, and 13 by activated protein C in human osteoarthritic cartilage chondrocytes.
Jackson MT; Moradi B; Smith MM; Jackson CJ; Little CB
Arthritis Rheumatol; 2014 Jun; 66(6):1525-36. PubMed ID: 24574263
[TBL] [Abstract][Full Text] [Related]
43. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice.
Romics L; Dolganiuc A; Kodys K; Drechsler Y; Oak S; Velayudham A; Mandrekar P; Szabo G
Hepatology; 2004 Sep; 40(3):555-64. PubMed ID: 15349893
[TBL] [Abstract][Full Text] [Related]
44. Follistatin-like protein 1 induction of matrix metalloproteinase 1, 3 and 13 gene expression in rheumatoid arthritis synoviocytes requires MAPK, JAK/STAT3 and NF-κB pathways.
Ni S; Li C; Xu N; Liu X; Wang W; Chen W; Wang Y; van Wijnen AJ
J Cell Physiol; 2018 Jan; 234(1):454-463. PubMed ID: 29932210
[TBL] [Abstract][Full Text] [Related]
45. The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes.
Kim HA; Cho ML; Choi HY; Yoon CS; Jhun JY; Oh HJ; Kim HY
Arthritis Rheum; 2006 Jul; 54(7):2152-63. PubMed ID: 16802353
[TBL] [Abstract][Full Text] [Related]
46. Involvement of TLR4 in the protective effect of intra-articular administration of curcumin on rat experimental osteoarthritis.
Yan D; He B; Guo J; Li S; Wang J
Acta Cir Bras; 2019 Aug; 34(6):e201900604. PubMed ID: 31432995
[TBL] [Abstract][Full Text] [Related]
47. Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling.
Kyburz D; Rethage J; Seibl R; Lauener R; Gay RE; Carson DA; Gay S
Arthritis Rheum; 2003 Mar; 48(3):642-50. PubMed ID: 12632416
[TBL] [Abstract][Full Text] [Related]
48. The potential molecular markers of inflammatory response in KOA with AD based on single-cell transcriptome sequencing analysis and identification of ligands by virtual screening.
Wu Y; Chen W; Jian J; Liu W; Wang H; Gao D; Liu W
Mol Divers; 2024 Apr; ():. PubMed ID: 38622351
[TBL] [Abstract][Full Text] [Related]
49. Toll-like receptors 4 and 2 expression in the bronchial mucosa of patients with cystic fibrosis.
Hauber HP; Tulic MK; Tsicopoulos A; Wallaert B; Olivenstein R; Daigneault P; Hamid Q
Can Respir J; 2005; 12(1):13-8. PubMed ID: 15776129
[TBL] [Abstract][Full Text] [Related]
50. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
[TBL] [Abstract][Full Text] [Related]
51. Overexpression of MMP13 in human osteoarthritic cartilage is associated with the SMAD-independent TGF-β signalling pathway.
Aref-Eshghi E; Liu M; Harper PE; Doré J; Martin G; Furey A; Green R; Rahman P; Zhai G
Arthritis Res Ther; 2015 Sep; 17(1):264. PubMed ID: 26395178
[TBL] [Abstract][Full Text] [Related]
52. Hyperbaric oxygen inhibits the HMGB1/RAGE signaling pathway by upregulating Mir-107 expression in human osteoarthritic chondrocytes.
Lin SS; Yuan LJ; Niu CC; Tu YK; Yang CY; Ueng SWN
Osteoarthritis Cartilage; 2019 Sep; 27(9):1372-1381. PubMed ID: 31146014
[TBL] [Abstract][Full Text] [Related]
53. TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype.
Quero L; Hanser E; Manigold T; Tiaden AN; Kyburz D
Arthritis Res Ther; 2017 Nov; 19(1):245. PubMed ID: 29096690
[TBL] [Abstract][Full Text] [Related]
54. Novel adipokine associated with OA: retinol binding protein 4 (RBP4) is produced by cartilage and is correlated with MMPs in osteoarthritis patients.
Scotece M; Koskinen-Kolasa A; Pemmari A; Leppänen T; Hämäläinen M; Moilanen T; Moilanen E; Vuolteenaho K
Inflamm Res; 2020 Apr; 69(4):415-421. PubMed ID: 32095874
[TBL] [Abstract][Full Text] [Related]
55. Anti‑inflammatory and anti‑catabolic effect of non‑animal stabilized hyaluronic acid and mesenchymal stem cell‑conditioned medium in an osteoarthritis coculture model.
Simental-Mendía M; Lozano-Sepúlveda SA; Pérez-Silos V; Fuentes-Mera L; Martínez-Rodríguez HG; Acosta-Olivo CA; Peña-Martínez VM; Vilchez-Cavazos F
Mol Med Rep; 2020 May; 21(5):2243-2250. PubMed ID: 32323772
[TBL] [Abstract][Full Text] [Related]
56. IL37 dampens the IL1β-induced catabolic status of human OA chondrocytes.
van Geffen EW; van Caam AP; van Beuningen HM; Vitters EL; Schreurs W; van de Loo FA; van Lent PL; Koenders MI; Blaney Davidson EN; van der Kraan PM
Rheumatology (Oxford); 2017 Mar; 56(3):351-361. PubMed ID: 27940589
[TBL] [Abstract][Full Text] [Related]
57. Increased expression of cyclooxygenase-2 in synovium tissues and synovial fluid from patients with knee osteoarthritis is associated with downregulated microRNA-758-3p expression.
Liu Z; Sun J; Liang T; Huang X
Exp Ther Med; 2021 Sep; 22(3):1001. PubMed ID: 34345283
[TBL] [Abstract][Full Text] [Related]
58. Bushenhuoxue formula attenuates cartilage degeneration in an osteoarthritic mouse model through TGF-β/MMP13 signaling.
Wang PE; Zhang L; Ying J; Jin X; Luo C; Xu S; Dong R; Xiao L; Tong P; Jin H
J Transl Med; 2018 Mar; 16(1):72. PubMed ID: 29554973
[TBL] [Abstract][Full Text] [Related]
59. Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by overexpression of Toll-like receptors 2 or 4.
Medvedev AE; Henneke P; Schromm A; Lien E; Ingalls R; Fenton MJ; Golenbock DT; Vogel SN
J Immunol; 2001 Aug; 167(4):2257-67. PubMed ID: 11490013
[TBL] [Abstract][Full Text] [Related]
60. Arthritis is associated with T-cell-induced upregulation of Toll-like receptor 3 on synovial fibroblasts.
Zhu W; Meng L; Jiang C; He X; Hou W; Xu P; Du H; Holmdahl R; Lu S
Arthritis Res Ther; 2011 Jun; 13(3):R103. PubMed ID: 21708001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
